SPACR Encoded by IMPG1 Is Essential for Photoreceptor Survival by Interplaying between the Interphotoreceptor Matrix and the Retinal Pigment Epithelium

Genes (Basel). 2022 Aug 23;13(9):1508. doi: 10.3390/genes13091508.

Abstract

Several pathogenic variants have been reported in the IMPG1 gene associated with the inherited retinal disorders vitelliform macular dystrophy (VMD) and retinitis pigmentosa (RP). IMPG1 and its paralog IMPG2 encode for two proteoglycans, SPACR and SPACRCAN, respectively, which are the main components of the interphotoreceptor matrix (IPM), the extracellular matrix surrounding the photoreceptor cells. To determine the role of SPACR in the pathological mechanisms leading to RP and VMD, we generated a knockout mouse model lacking Impg1, the mouse ortholog. Impg1-deficient mice show abnormal accumulation of autofluorescent deposits visible by fundus imaging and spectral-domain optical coherence tomography (SD-OCT) and attenuated electroretinogram responses from 9 months of age. Furthermore, SD-OCT of Impg1-/- mice shows a degeneration of the photoreceptor layer, and transmission electron microscopy shows a disruption of the IPM and the retinal pigment epithelial cells. The decrease in the concentration of the chromophore 11-cis-retinal supports this loss of photoreceptors. In conclusion, our results demonstrate the essential role of SPACR in maintaining photoreceptors. Impg1-/- mice provide a novel model for mechanistic investigations and the development of therapies for VMD and RP caused by IMPG1 pathogenic variants.

Keywords: IMPG1; IMPG2; SPACR; SPACRCAN; retinitis pigmentosa; vitelliform macular dystrophy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Extracellular Matrix / genetics
  • Extracellular Matrix / pathology
  • Extracellular Matrix Proteins* / genetics
  • Eye Proteins* / genetics
  • Mice
  • Photoreceptor Cells / pathology
  • Proteoglycans* / genetics
  • Retinal Pigment Epithelium / pathology
  • Retinal Pigments
  • Retinaldehyde
  • Retinitis Pigmentosa* / genetics
  • Retinitis Pigmentosa* / pathology
  • Vitelliform Macular Dystrophy* / genetics

Substances

  • Extracellular Matrix Proteins
  • Eye Proteins
  • IMPG1 protein, mouse
  • Proteoglycans
  • Retinal Pigments
  • Retinaldehyde

Grants and funding

This research was funded by the Valentin Haüy/Retina France association, grant number #RAK18006FFA, by SOS Rétinite Pigmentaire foundation, grant number #20142016/1051, and by the French Foundation for Rare Disease, grant number #201607.